Article
A comprehensive analysis of immune landscape of Indian triple negative breast cancer
2022-03-07
Abstract excerpt
<h4>Background</h4> Triple-negative breast cancer (TNBC) is a heterogeneous disease with a significant clinical challenge. TNBC alarmingly comprises 25-30% of breast cancers in India compared with only 10-15% in the West. However, immunotherapy was approved for high-risk early-stage TNBCs in the West. Hence, a long-standing question is whether Indian TNBCs immunologically and clinically resemble Western TNBCs suc...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1bdb01f8-40d3-5357-b5ad-2efc69615817
- DOI
- 10.1101/2022.03.06.483159
